PubMed

Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma.

Sharma S, Neale MH, Di Nicolantonio F, Knight LA, Whitehouse PA, Mercer SJ, Higgins BR, Lamont A, Osborne R, Hindley AC, Kurbacher CM, Cree IA.

BMC Cancer. 2003 Jul 3;3:19.PMID: 12841853 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancer.

Kurbacher CM, Cree IA, Bruckner HW, Brenne U, Kurbacher JA, Müller K, Ackermann T, Gilster TJ, Wilhelm LM, Engel H, Mallmann PK, Andreotti PE.

Anticancer Drugs. 1998 Jan;9(1):51-7.PMID: 9491792 [PubMed - indexed for MEDLINE]Related articles

Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.

Konecny G, Crohns C, Pegram M, Felber M, Lude S, Kurbacher C, Cree IA, Hepp H, Untch M.

Gynecol Oncol. 2000 May;77(2):258-63.PMID: 10785475 [PubMed - indexed for MEDLINE]Related articles

A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer.

Cree IA, Kurbacher CM, Lamont A, Hindley AC, Love S; TCA Ovarian Cancer Trial Group.

Anticancer Drugs. 2007 Oct;18(9):1093-101.PMID: 17704660 [PubMed - indexed for MEDLINE]Related articles

-Chemosensitivity testing in gynecologic oncology. Experiences with an ATP bioluminescence assay-.

Kurbacher CM, Mallmann P, Kurbacher JA, Hübner H, Krebs D.

Geburtshilfe Frauenheilkd. 1996 Feb;56(2):70-8. German. PMID: 8647362 [PubMed - indexed for MEDLINE]Related articles

ATP chemosensitivity testing in ovarian and breast cancer: early clinical trials.

Kurbacher CM, Grecu OM, Stier U, Gilster TJ, Janát MM, Untch M, Konecny G, Bruckner HW, Cree IA.

Recent Results Cancer Res. 2003;161:221-30. Review.PMID: 12528810 [PubMed - indexed for MEDLINE]Related articles

[Correlation between ATP bioluminescence tumor chemosensitivity assay and clinical response in ovarian cancer]

Tian HM, Shi XY, Fu J, Chao DY, Zhang K, Wu LY, Wang JW, Zhang W.

Zhonghua Zhong Liu Za Zhi. 2005 May;27(5):296-8. Chinese. PMID: 15996325 [PubMed - indexed for MEDLINE]Related articles

Clinical applicability of the ATP cell viability assay as a predictor of chemoresponse in platinum-resistant epithelial ovarian cancer using nonsurgical tumor cell samples.

Ng TY, Ngan HY, Cheng DK, Wong LC.

Gynecol Oncol. 2000 Mar;76(3):405-8.PMID: 10684718 [PubMed - indexed for MEDLINE]Related articles

Is pretreatment hemoglobin level a predictor of complete response to salvage chemotherapy for recurrent platinum-pretreated ovarian carcinoma?

Gadducci A, Cosio S, Fanucchi A, Tanganelli L, Conte PF, Cristofani R, Genazzani AR.

Eur J Gynaecol Oncol. 2003;24(5):405-10.PMID: 14584657 [PubMed - indexed for MEDLINE]Related articles

Progression-free interval in ovarian cancer and predictive value of an ex vivo chemoresponse assay.

Gallion H, Christopherson WA, Coleman RL, DeMars L, Herzog T, Hosford S, Schellhas H, Wells A, Sevin BU.

Int J Gynecol Cancer. 2006 Jan-Feb;16(1):194-201.PMID: 16445633 [PubMed - indexed for MEDLINE]Related articles

Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer.

Hasan J, Ton N, Mullamitha S, Clamp A, McNeilly A, Marshall E, Jayson GC.

Br J Cancer. 2005 Sep 19;93(6):647-51.PMID: 16222310 [PubMed - indexed for MEDLINE]Related articlesFree article

In vitro drug sensitivity predicts response and survival after individualized sensitivity-directed chemotherapy in metastatic melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group.

Ugurel S, Schadendorf D, Pföhler C, Neuber K, Thoelke A, Ulrich J, Hauschild A, Spieth K, Kaatz M, Rittgen W, Delorme S, Tilgen W, Reinhold U; Dermatologic Cooperative Oncology Group.

Clin Cancer Res. 2006 Sep 15;12(18):5454-63.PMID: 17000680 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and hematologic toxicity of salvage chemotherapy following stem cell-supported high-dose chemotherapy in women with recurrent ovarian cancer.

Cook S, Penson R, Duska L, Nikrui N, Goodman A, Fuller A, Seiden M.

Gynecol Oncol. 2000 Apr;77(1):48-54.PMID: 10739690 [PubMed - indexed for MEDLINE]Related articles

Treatment of recurrent ovarian cancer: a retrospective analysis of women treated with single-agent carboplatin originally treated with carboplatin and paclitaxel. The Memorial Sloan-Kettering Cancer Center experience.

Dizon DS, Dupont J, Anderson S, Sabbatini P, Hummer A, Aghajanian C, Spriggs D.

Gynecol Oncol. 2003 Dec;91(3):584-90.PMID: 14675681 [PubMed - indexed for MEDLINE]Related articles

Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivity.

Cree IA, Kurbacher CM, Untch M, Sutherland LA, Hunter EM, Subedi AM, James EA, Dewar JA, Preece PE, Andreotti PE, Bruckner HW.

Anticancer Drugs. 1996 Aug;7(6):630-5.PMID: 8913430 [PubMed - indexed for MEDLINE]Related articles

Predicting resistance to platinum-containing chemotherapy with the ATP tumor chemosensitivity assay in primary ovarian cancer.

Neubauer H, Stefanova M, Solomayer E, Meisner C, Zwirner M, Wallwiener D, Fehm T.

Anticancer Res. 2008 Mar-Apr;28(2A):949-55.PMID: 18507041 [PubMed - indexed for MEDLINE]Related articles

Combined oral cyclophosphamide and bevacizumab in heavily pre-treated ovarian cancer.

Jurado JM, Sánchez A, Pajares B, Pérez E, Alonso L, Alba E.

Clin Transl Oncol. 2008 Sep;10(9):583-6. Erratum in: Clin Transl Oncol. 2008 Nov;10(11):772. Jurado García, José Miguel [corrected to Jurado, José Miguel]. PMID: 18796376 [PubMed - indexed for MEDLINE]Related articles

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.PMID: 16414206 [PubMed - indexed for MEDLINE]Related articles

Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer.

Aravantinos G, Bafaloukos D, Fountzilas G, Christodoulou C, Papadimitriou C, Pavlidis N, Kalofonos HP, Gogas H, Kosmidis P, Dimopoulos MA.

Ann Oncol. 2003 Jul;14(7):1094-9.PMID: 12853352 [PubMed - indexed for MEDLINE]Related articlesFree article

Individualized long-term chemotherapy for recurrent ovarian cancer after failing high-dose treatment.

Breidenbach M, Rein DT, Mallmann P, Kurbacher CM.

Anticancer Drugs. 2002 Feb;13(2):173-6.PMID: 11901311 [PubMed - indexed for MEDLINE]Related articles